| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ITCH_0006600 | Exon-Exon | chr20:32996457-33001685 | chr20:34408651-34413879 | 405 nt | 0.3901 |
| hsa_ITCH_0007700 | Exon-Exon | chr20:33000321-33001685 | chr20:34412515-34413879 | 263 nt | 0.3802 |
| hsa_ITCH_0007800 | Exon-Exon | chr20:33000321-33030108 | chr20:34412515-34442303 | 876 nt | 0.4566 |
| hsa_ITCH_0009000 | Exon-Exon | chr20:33001548-33001685 | chr20:34413742-34413879 | 138 nt | 0.4058 |
| hsa_ITCH_0010000 | Exon-Exon | chr20:33001548-33012331 | chr20:34413742-34424525 | 184 nt | 0.4185 |
| hsa_ITCH_0010300 | Exon-Exon | chr20:33001548-33028149 | chr20:34413742-34440344 | 532 nt | 0.4530 |
| hsa_ITCH_0009100 | Exon-Exon | chr20:33001548-33030108 | chr20:34413742-34442303 | 751 nt | 0.4740 |
| hsa_ITCH_0010500 | Exon-Exon | chr20:33001548-33037285 | chr20:34413742-34449480 | 873 nt | 0.4559 |
| hsa_ITCH_0009200 | Exon-Exon | chr20:33001548-33045279 | chr20:34413742-34457474 | 1081 nt | 0.4662 |
| hsa_ITCH_0009300 | Exon-Exon | chr20:33001548-33050026 | chr20:34413742-34462221 | 1210 nt | 0.4603 |
A review consolidating research in humans and model organisms indicates that the circITCH functions as a tumor suppressor in glioma by sponging miR-214 to allow expression of ubiquitin-protein ligase E3, thereby suppressing proliferation and preventing apoptosis, while also targeting the Wnt/β-catenin pathway [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. In oesophageal squamous cell carcinoma, the circITCH is downregulated and increases ITCH expression to inhibit the Wnt/β-catenin pathway [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. circITCH hsa_circ_0001141 (circITCH) was found to be lower in the hearts of cancer patients suffering from doxorubicin-induced cardiomyopathy compared to those with dilated cardiomyopathy, hypertrophic cardiomyopathy, and healthy donors, and its expression ameliorates doxorubicin-induced cardiomyocyte injury [Tian et al. DOI:10.3390/molecules26041155].